Myriad Genetics Earnings
NASDAQ: MYGNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
4.31+0.11 (+2.62%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.24
Myriad Genetics earnings summary
Myriad Genetics is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $-0.24.
Summary generated from market data by MetaCap's automated system. Methodology